SAMSUNG PHARM. Co., LTD. (KOSE: A001360)
Health Care · Pharmaceuticals · KR
₩1,376.00
-3.98% today · -12.7% 1Y
SAMSUNG PHARM. Co., LTD. (KOSE: A001360) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $96.33M.
Over the last twelve months the share price has lost 12.7%, trading between 1.14K and 2.32K.
Tweenvest scores SAMSUNG PHARM. Co., LTD. across four factors: quality 56/100, value 46/100, growth 52/100. Its strongest factor is quality.
A001360 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $96.33M
- Revenue (TTM)
- $29.98M
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- 0.73
- 52-week high
- ₩2,320.00
- 52-week low
- ₩1,140.00
- Avg volume (3M)
- —
- Shares outstanding
- 94.12M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| PT Darya-Varia Laboratoria TbkIDX: DVLA | $99.21M | Rp1,585.00 | +0.32% |
| Kyongbo Pharmaceutical Co., LtdKOSE: A214390 | $97.81M | ₩5,500.00 | +1.48% |
| Infant Bacterial Therapeutics AB (publ)OM: IBT B | $97.54M | Skr72.40 | +4.17% |
| The Jordanian Pharmaceutical Manufacturing Company - Public Shareholding CompanyASE: JPHM | $97.38M | JD1.52 | -1.30% |
| Fusen Pharmaceutical Company LimitedSEHK: 1652 | $95.62M | HK$1.02 | +9.73% |
| Pak Fah Yeow International LimitedSEHK: 239 | $94.91M | HK$2.39 | -2.45% |
| Merdury Biopharmaceutical CorporationTPEX: 6932 | $94.16M | NT$7.04 | +15.22% |
| Unité de Fabrication des Médicaments S.ABVMT: UMED | $93.89M | DT8.77 | -0.34% |
Figures last refreshed Oct 11, 2026.